The Australasian Cerebral Palsy (CP) Clinical Trials Network has a work plan to uplift earlier detection of CP, fast track children to multisite randomised clinical trials of new neuroprotectants and to develop and test new rehabilitation. Knowledge translation studies will ensure effective transfer to enhanced clinical practice. The CRE will overcome known barriers to implementation, developing international clinical practice guidelines guided by a consumer network. The changes in outcomes of children with CP due to the new clinical trials will be tested in Australian Cerebral Palsy Register (ACPR).
|Short title||Australasian Cerebral Palsy Clinical Trials Network|
|Effective start/end date||1/01/16 → 31/10/21|
- National Health and Medical Research Council (NHMRC) (Australia): A$2,499,287.00